Baxter International is set to announce its latest earnings this Thursday, showcasing a Q1 revenue of $2.97 billion, an 8% increase year-over-year that topped Wall Street expectations. Despite this strong performance, the company faced challenges, including a reported net loss of $15 million and missed full-year EPS guidance, raising concerns among investors reflected in its current Zacks Rank of #4 (Sell). With shares trading at $18.02 against an average analyst price target of $22.12, Baxter shows a potential upside of 26% as it navigates ongoing financial and operational hurdles.